These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19427446

  • 1. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB, Breen JB, Rogers P, Johnson PH, Smith J, Smolenski RT, Banner NR, Yacoub MH, Barton PJ.
    Am J Cardiol; 2009 May 15; 103(10):1457-62. PubMed ID: 19427446
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA.
    Am Heart J; 2006 Aug 15; 152(2):312-20. PubMed ID: 16875916
    [Abstract] [Full Text] [Related]

  • 3. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
    Morrow WR, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, McGiffin DC, Kirklin JK.
    J Heart Lung Transplant; 1997 Dec 15; 16(12):1255-66. PubMed ID: 9436138
    [Abstract] [Full Text] [Related]

  • 4. Does duration of donor brain injury affect outcome after orthotopic pediatric heart transplantation?
    Odim J, Laks H, Banerji A, Mukherjee K, Vincent C, Murphy C, Burch C, Gjertson D.
    J Thorac Cardiovasc Surg; 2005 Jul 15; 130(1):187-93. PubMed ID: 15999061
    [Abstract] [Full Text] [Related]

  • 5. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E.
    Int J Cardiol; 2005 May 25; 101(2):191-5. PubMed ID: 15882662
    [Abstract] [Full Text] [Related]

  • 6. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
    Yuen AH, Yacoub MH, Birks EJ, Kalsi KK, Johnson PH, Smolenski RT.
    Nucleosides Nucleotides Nucleic Acids; 2005 May 25; 24(4):275-7. PubMed ID: 16021915
    [Abstract] [Full Text] [Related]

  • 7. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA.
    Circulation; 2006 Jul 04; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [Abstract] [Full Text] [Related]

  • 8. Effect of older donor age on risk for mortality after heart transplantation.
    Gupta D, Piacentino V, Macha M, Singhal AK, Gaughan JP, McClurken JB, Goldman BI, Fisher CA, Beltramo D, Monacchio J, Eisen HJ, Furukawa S.
    Ann Thorac Surg; 2004 Sep 04; 78(3):890-9. PubMed ID: 15337016
    [Abstract] [Full Text] [Related]

  • 9. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR.
    Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700
    [Abstract] [Full Text] [Related]

  • 10. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients.
    Singh TP, Edwards LB, Kirk R, Boucek MM.
    J Heart Lung Transplant; 2009 Dec 15; 28(12):1285-91. PubMed ID: 19782597
    [Abstract] [Full Text] [Related]

  • 11. Decreased recipient survival following orthotopic heart transplantation with use of hearts from donors with projectile brain injury.
    Karamlou T, Shen I, Slater M, Crispell K, Chan B, Ravichandran P.
    J Heart Lung Transplant; 2005 Jan 15; 24(1):29-33. PubMed ID: 15653375
    [Abstract] [Full Text] [Related]

  • 12. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.
    Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora JL.
    J Heart Lung Transplant; 1994 Jan 15; 13(3):353-64; discussion 364-5. PubMed ID: 8061010
    [Abstract] [Full Text] [Related]

  • 13. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era.
    Weiss ES, Allen JG, Patel ND, Russell SD, Baumgartner WA, Shah AS, Conte JV.
    Circ Heart Fail; 2009 Sep 15; 2(5):401-8. PubMed ID: 19808369
    [Abstract] [Full Text] [Related]

  • 14. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
    Auerbach SR, Manlhiot C, Reddy S, Kinnear C, Richmond ME, Gruber D, McCrindle BW, Deng L, Chen JM, Addonizio LJ, Chung WK, Mital S.
    J Am Coll Cardiol; 2009 May 19; 53(20):1909-17. PubMed ID: 19442892
    [Abstract] [Full Text] [Related]

  • 15. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C.
    Am Heart J; 2006 Oct 19; 152(4):736-41. PubMed ID: 16996850
    [Abstract] [Full Text] [Related]

  • 16. Cardiac retransplantation: is it justified in times of critical donor organ shortage? Long-term single-center experience.
    Goerler H, Simon A, Gohrbandt B, Hagl C, Oppelt P, Haverich A, Strueber M.
    Eur J Cardiothorac Surg; 2008 Dec 19; 34(6):1185-90. PubMed ID: 18693029
    [Abstract] [Full Text] [Related]

  • 17. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
    Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, Upton MP, Reyes JD, Perkins JD.
    Liver Transpl; 2010 Jul 19; 16(7):874-84. PubMed ID: 20583086
    [Abstract] [Full Text] [Related]

  • 18. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database.
    Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, Conte JV.
    Circulation; 2008 Sep 30; 118(14 Suppl):S83-8. PubMed ID: 18824775
    [Abstract] [Full Text] [Related]

  • 19. Hearts from donors with chronic alcohol use: a possible risk factor for death after heart transplantation.
    Freimark D, Aleksic I, Trento A, Takkenberg JJ, Valenza M, Admon D, Blanche C, Queral CA, Azen CG, Czer LS.
    J Heart Lung Transplant; 1996 Feb 30; 15(2):150-9. PubMed ID: 8672518
    [Abstract] [Full Text] [Related]

  • 20. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL.
    J Card Fail; 2005 Dec 30; 11(9):677-83. PubMed ID: 16360962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.